Monoclonal anti-FH antibody treatments have been used successfully in vitro and in a lung cancer mouse model in vivo (156, 157), and the FH monoclonal antibody is currently in a Phase Ib clinical trial for advanced lung cancer. The gene discussed is FH; the disease is lung carcinoma.